Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 38

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 38
---
 Scheme Implementation Deed, as amended and restated on September 13, 2023,
between Incannex Australia and the Company. As a result of the redomiciliation, Incannex Australia became a wholly-owned subsidiary of
Incannex Healthcare Inc.

Our principal office is located at Suite 105,
8 Century Circuit, Norwest 2153, NSW Australia and our telephone number is +61 409 840 786. Our address on the Internet is http://www.incannex.com.
The reference to our website address does not constitute incorporation by reference of the information contained at or available through
our website, and you should not consider it to be a part of this prospectus.

The information on, or accessible through, our
website is not part of this prospectus. We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K
and amendments to those reports with SEC. Our filings with the SEC are available free of charge on the SEC’s website and on the
“Investors” section of our website as soon as reasonably practicable after we electronically file such material with, or furnish
it to, the SEC. The SEC maintains an internet site that contains reports and information statements, and other information regarding issuers
that file electronically with the SEC at http://www.sec.gov.

<div align='center'>1</div>

Offerings Under This Prospectus Under this prospectus, we may offer shares of our common stock or preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in units, with a total aggregate offering price of up to $150.0 million, from time to time at prices and on terms to be determined by market conditions at the time of the offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable:

| ● | designation        
 or classification; |

| ● | aggregate                                     
 principal amount or aggregate offering price; |

| ● | maturity,      
 if applicable; |

| ● | rates                                                  
 and times of payment of interest or dividends, if any; |

| ● | redemption,                               
 conversion or sinking fund terms, if any; |

| ● | voting                       
 or other rights, if any; and |